Reference health

Biotin-8-hydroxyquinoline conjugates and their metal complexes: Exploring the chemical properties and the antioxidant activity

https://doi.org/10.1016/j.poly.2016.02.025
CiteStamped reference-health badge
59/59 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 59 checked references that resolve
resolves10.1039/C4MD00284A
8-Hydroxyquinoline: a privileged structure with a broad-ranging pharmacological potential
resolves10.2147/DDDT.S49763
8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications
resolves10.2174/092986711795328382
Quinoline as a Privileged Scaffold in Cancer Drug Discovery
resolves10.1021/ic0494051
Clioquinol, a Drug for Alzheimer's Disease Specifically Interfering with Brain Metal Metabolism:  Structural Characterization of Its Zinc(II) and Copper(II) Complexes
resolves10.1016/j.jinorgbio.2010.08.014
Hydroxyquinoline based binders: Promising ligands for chelatotherapy?
resolves10.1016/j.jns.2003.11.007
Clinical analysis of longstanding subacute myelo-optico-neuropathy: sequelae of clioquinol at 32 years after its ban
resolves10.1016/j.ab.2007.10.041
A time-resolved, internally quenched fluorescence assay to characterize inhibition of hepatitis C virus nonstructural protein 3–4A protease at low enzyme concentrations
resolves10.1016/S0022-510X(99)00297-X
Changes in uptake of vitamin B12 and trace metals in brains of mice treated with clioquinol
resolves10.1111/j.1755-5949.2010.00231.x
Clioquinol: Review of its Mechanisms of Action and Clinical Uses in Neurodegenerative Disorders
resolves10.1111/j.1399-3011.2005.00289.x
Synthesis and evaluation of peptidic metal chelators for neuroprotection in neurodegenerative diseases
resolves10.1002/cbic.200900597
A Prochelator Activated by Hydrogen Peroxide Prevents Metal‐Induced Amyloid β Aggregation
resolves10.1002/open.201500155
New Glycoconjugates for the Treatment of Diseases Related to Metal Dyshomeostasis
resolves10.1021/cb900264w
Site-Activated Chelators Targeting Acetylcholinesterase and Monoamine Oxidase for Alzheimer’s Therapy
resolves10.1002/wnan.59
Quinoline‐<i>n</i>‐butylcyanoacrylate‐based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease
resolves10.1039/c3sc50697e
Cerium oxide caged metal chelator: anti-aggregation and anti-oxidation integrated H2O2-responsive controlled drug release for potential Alzheimer's disease treatment
resolves10.1039/C2DT32429F
Glycosylated copper( <scp>ii</scp> ) ionophores as prodrugs for β-glucosidase activation in targeted cancer therapy
resolves10.1016/j.jinorgbio.2014.09.017
New 8-hydroxyquinoline galactosides. The role of the sugar in the antiproliferative activity of copper(II) ionophores
resolves10.1021/ic502713f
Soluble Sugar-Based Quinoline Derivatives as New Antioxidant Modulators of Metal-Induced Amyloid Aggregation
resolves10.1002/cplu.201402450
Cyclodextrin 3‐Functionalized with 8‐Hydroxyquinoline as an Antioxidant Inhibitor of Metal‐Induced Amyloid Aggregation
resolves10.1002/chem.201402690
Multifunctional 8‐Hydroxyquinoline‐Appended Cyclodextrins as New Inhibitors of Metal‐Induced Protein Aggregation
resolves10.1002/biof.5520260105
Vitamin B<sub>12</sub>and methionine synthesis: A critical review. Is nature's most beautiful cofactor misunderstood?
resolves10.1517/17425241003677749
Avidin-biotin technology in targeted therapy
resolves10.1016/j.ejmech.2008.04.021
Targeting cancer cells with biotin–dendrimer conjugates
resolves10.1021/ja401350x
Gemcitabine–Coumarin–Biotin Conjugates: A Target Specific Theranostic Anticancer Prodrug
resolves10.1016/j.ejmech.2013.10.002
New derivative of carnosine for nanoparticle assemblies
resolves10.1007/s00253-013-5232-z
Streptavidin–biotin technology: improvements and innovations in chemical and biological applications
resolves10.1006/abbi.1999.1213
Molecular and Functional Characterization of the Intestinal Na+-Dependent Multivitamin Transporter
resolves10.1023/A:1010932126662
Targeting the Sodium-Dependent Multivitamin Transporter (SMVT) for Improving the Oral Absorption Properties of a Retro-Inverso Tat Nonapeptide
resolves10.1016/S0168-3659(01)00474-6
Targeted PEG-based bioconjugates enhance the cellular uptake and transport of a HIV-1 TAT nonapeptide
resolves10.1074/jbc.M010907200
Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation
resolves10.1074/jbc.M105343200
Metal-triggered Structural Transformations, Aggregation, and Fibrillation of Human α-Synuclein
resolves10.1016/j.tet.2005.08.031
Amide bond formation and peptide coupling
resolves10.1002/chem.201502155
Unusual Cyclodextrin Derivatives as a New Avenue to Modulate Self‐ and Metal‐Induced Aβ Aggregation
resolves10.3390/12081910
Biological Activities of Hydrazone Derivatives
resolves10.1016/S0040-4020(01)87332-4
Conformational behaviour and / isomerization of -acyl and -aroylhydrazones
resolves10.1021/cg401866x
Substituent and Solvent Effects on Intermolecular Interactions in Crystals of <i>N</i>-Acylhydrazone Derivatives: Single-Crystal X-ray, Solid-State NMR, and Computational Studies
resolves10.1016/j.ejmech.2009.03.032
Synthesis, spectral characterization, in-vitro microbiological evaluation and cytotoxic activities of novel macrocyclic bis hydrazone
resolves10.1016/S0223-5234(00)90179-X
Synthesis, characterization and pharmacological properties of some 4-arylhydrazono-2-pyrazoline-5-one derivatives obtained from heterocyclic amines
resolves10.1016/j.ejmech.2003.08.004
Synthesis and biological activities of diflunisal hydrazide–hydrazones
resolves10.1002/ange.200802651
Hydrolytic Stability of Hydrazones and Oximes
resolves10.1039/c0mt00074d
Role of metal dyshomeostasis in Alzheimer's disease
resolves10.1155/2013/726954
Metal Dyshomeostasis and Inflammation in Alzheimer’s and Parkinson’s Diseases: Possible Impact of Environmental Exposures
resolves10.1016/j.ctrv.2008.07.004
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
resolves10.1016/j.ica.2011.11.033
Studies on the effect of metal ions of hydrazone complexes on interaction with nucleic acids, bovine serum albumin and antioxidant properties
resolves10.1002/ejic.201501198
A 8‐Hydroxyquinoline‐Cyclodextrin Conjugate as an Efficient Chelating Agent for Cobalt(II) and Nickel(II) in Neutral Aqueous Solution
resolves10.1021/ac0261101
Complexation of Copper by Zwitterionic Aminosulfonic (Good) Buffers
resolves10.1016/j.saa.2005.08.008
Synthesis and spectroscopic studies of mixed-ligand and polymeric dinuclear transition metal complexes with bis-acylhydrazone tetradentate ligands and 1,10-phenanthroline
resolves10.1016/j.ejmech.2010.01.033
New Cu(II), Co(II), Ni(II) complexes with aroyl-hydrazone based ligand. Synthesis, spectroscopic characterization and in vitro antibacterial evaluation
resolves10.1016/j.ica.2007.03.001
Potential tridentate salicylaldehyde hydrazone of arylalkanoic acid coordinate to copper(II) acting as dinegative tetradentate ligands
resolves10.1021/jo01307a026
Methylation of nucleosides with trimethylsulfonium hydroxide. Effects of transition metal ions
resolves10.1016/j.saa.2006.07.052
Synthesis and characterization of iron(III), manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II) complexes of salicylidene-N-anilinoacetohydrazone (H2L1) and 2-hydroxy-1-naphthylidene-N-anilinoacetohydrazone (H2L2)
resolves10.1039/C0DT01176B
Copper( <scp>ii</scp> ) complexes of hybrid hydroxyquinoline-thiosemicarbazone ligands: GSK3β inhibition due to intracellular delivery of copper
resolves10.1089/ars.2006.8.1971
Oxidative Stress in Neurodegenerative Disorders
resolves10.1016/j.mad.2006.12.008
Age-related changes in mitochondrial function and antioxidative enzyme activity in fischer 344 rats
resolves10.1016/S0009-3084(00)00120-1
Antioxidant activities of estrogens against aqueous and lipophilic radicals; differences between phenol and catechol estrogens
resolves10.1016/j.foodchem.2010.07.047
Determination of polyphenols content and antioxidant activity of some red wines by differential pulse voltammetry, HPLC and spectrophotometric methods
resolves10.1016/S0891-5849(03)00325-3
Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin
resolves10.1021/jm100329q
Novel Tacrine−8-Hydroxyquinoline Hybrids as Multifunctional Agents for the Treatment of Alzheimer’s Disease, with Neuroprotective, Cholinergic, Antioxidant, and Copper-Complexing Properties
resolves10.1149/1.2427458
EDTA Titrations; An Introduction to Theory and Practice
The 3 references without a DOI — listed, not checked
no DOI — not checked10.1016/j.poly.2016.02.025_b0055
no DOI — not checkedMetals and metal compounds in cancer treatment
no DOI — not checkedNew insights on oxidative stress in cancer
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.poly.2016.02.025"><img src="https://citestamp.com/citestamped/10.1016/j.poly.2016.02.025/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.poly.2016.02.025/badge.svg)](https://citestamp.com/citestamped/10.1016/j.poly.2016.02.025)